Back

Mechanical circulatory support with microaxial flow pump for high-risk PCI: a comparative analysis in left main disease

30 August 2025 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Outcomes in left main percutaneous coronary intervention Protected Percutaneous Coronary Intervention (PCI) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Giulia Botti

San Raffaele Hospital, Milan (Italy)

8 More presentations in this session

Presentation thumbnail
Cardiovascular events following directional coronary atherectomy: a comparison of drug-coated balloon vs. newer-generation drug-eluting stent in left main coronary artery bifurcation lesions
Doctor K. Murai (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Ostial stent coverage in LMCA PCI: impact on long-term outcomes
Assistant Professor Y. Takei (Yokohama, JP)
Abstract Slides Video
Presentation thumbnail
Stent expansion in novel platinum-chromium versus conventional cobalt-chromium everolimus-eluting stents for left main coronary artery disease: the MAGARS-LM study
Doctor T. Warisawa (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Five-year outcome after unprotected distal left main percutaneous coronary interventions according to complexity defined by DEFINITION criteria
Doctor O. Nemeth (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes of management options for significant unprotected left main coronary artery disease
Assistant Professor G. Tan (Shatin, HK)
Abstract Slides Video

Access the full session

Session thumbnail
Outcomes in left main percutaneous coronary intervention

The Event

Event poster

ESC Congress 2025

30 August 2025 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Mechanical circulatory support in left main coronary intervention: experience from a high-volume tertiary centre
thumbnail
Congress Session
Long-term outcomes and innovations in revascularisation strategies
thumbnail
Congress Presentation
Approach to left main disease in 2023: PCI vs. CABG

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources